MARSHALL WACE, LLP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 72 filers reported holding TRANSMEDICS GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$31,599,130
+8086.3%
577,153
+2763.0%
0.06%
+6300.0%
Q4 2021$386,000
+5.8%
20,159
+128.9%
0.00%
-50.0%
Q1 2021$365,000
+9.3%
8,805
-63.7%
0.00%0.0%
Q3 2020$334,000
+25.1%
24,252
+62.8%
0.00%0.0%
Q2 2020$267,00014,8980.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2020
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders